Inflammation and aging: signaling pathways and intervention therapies

X Li, C Li, W Zhang, Y Wang, P Qian… - Signal Transduction and …, 2023 - nature.com
Aging is characterized by systemic chronic inflammation, which is accompanied by cellular
senescence, immunosenescence, organ dysfunction, and age-related diseases. Given the …

CD39/CD73/A2AR pathway and cancer immunotherapy

C Xia, S Yin, KKW To, L Fu - Molecular cancer, 2023 - Springer
Cancer development is closely associated with immunosuppressive tumor
microenvironment (TME) that attenuates antitumor immune responses and promotes tumor …

Spatial biology of cancer evolution

Z Seferbekova, A Lomakin, LR Yates… - Nature Reviews …, 2023 - nature.com
The natural history of cancers can be understood through the lens of evolution given that the
driving forces of cancer development are mutation and selection of fitter clones. Cancer …

Designing cancer immunotherapies that engage T cells and NK cells

O Kyrysyuk, KW Wucherpfennig - Annual review of immunology, 2023 - annualreviews.org
T cells and natural killer (NK) cells have complementary roles in tumor immunity, and dual T
cell and NK cell attack thus offers opportunities to deepen the impact of immunotherapy …

NK cells and solid tumors: therapeutic potential and persisting obstacles

L Tong, C Jiménez-Cortegana, AHM Tay, S Wickström… - Molecular cancer, 2022 - Springer
Natural killer (NK) cells, which are innate lymphocytes endowed with potent cytotoxic
activity, have recently attracted attention as potential anticancer therapeutics. While NK cells …

Harnessing IL-15 signaling to potentiate NK cell-mediated cancer immunotherapy

S Ma, MA Caligiuri, J Yu - Trends in immunology, 2022 - cell.com
Natural killer (NK) cells, a crucial component of the innate immune system, have long been
of clinical interest for their antitumor properties. Almost every aspect of NK cell immunity is …

Natural killer cell therapies

E Vivier, L Rebuffet, E Narni-Mancinelli, S Cornen… - Nature, 2024 - nature.com
Natural killer (NK) cells are lymphocytes of the innate immune system. A key feature of NK
cells is their ability to recognize a wide range of cells in distress, particularly tumour cells …

Intravenous administration of BCG in mice promotes natural killer and T cell-mediated antitumor immunity in the lung

E Moreo, A Jarit-Cabanillas, I Robles-Vera… - Nature …, 2023 - nature.com
Abstract Intravesical administration of Bacillus Calmette-Guérin (BCG) was one of the first
FDA-approved immunotherapies and remains a standard treatment for bladder cancer …

Targeting MHC-I molecules for cancer: function, mechanism, and therapeutic prospects

X Wu, T Li, R Jiang, X Yang, H Guo, R Yang - Molecular cancer, 2023 - Springer
The molecules of Major histocompatibility class I (MHC-I) load peptides and present them on
the cell surface, which provided the immune system with the signal to detect and eliminate …

New immune cell engagers for cancer immunotherapy

A Fenis, O Demaria, L Gauthier, E Vivier… - Nature Reviews …, 2024 - nature.com
There have been major advances in the immunotherapy of cancer in recent years, including
the development of T cell engagers—antibodies engineered to redirect T cells to recognize …